Helen of Troy Limited — Form 10-K Summary
Reporting period: Fiscal year ended February 28, 2023, filed April 27, 2023. The source refers to the annual fiscal 2023 period rather than a standalone 2022 fourth quarter. Helen of Troy is a global consumer products company operating in two reportable segments: Home & Outdoor and Beauty & Wellness. Comparative segment data was recast after Health & Wellness and Beauty were combined into Beauty & Wellness during the fourth quarter.
Financial Results and Key Metrics
| Metric | Fiscal 2023 | Fiscal 2022 | Change |
|---|---|---|---|
| Net sales | $2,072.7 million | $2,223.4 million | Down 6.8% |
| Gross profit | $899.4 million | $953.2 million | Down 5.6% |
| Gross margin | 43.4% | 42.9% | Up 0.5 percentage points |
| Operating income | $211.8 million | $272.6 million | Down 22.3% |
| Operating margin | 10.2% | 12.3% | Down 2.1 percentage points |
| Adjusted operating income | $300.9 million | $355.1 million | Down 15.3% |
| Adjusted operating margin | 14.5% | 16.0% | Down 1.5 percentage points |
| Net income | $143.3 million | $223.8 million | Down 36.0% |
| Diluted EPS | $5.95 | $9.17 | Down 35.1% |
| Adjusted diluted EPS | $9.45 | $12.36 | Down 23.5% |
| Cash flow from operations | $208.2 million | $140.8 million | Up $67.4 million |
- Segment sales: Home & Outdoor sales increased 5.8% to $915.7 million, primarily from a full year of Osprey results. Beauty & Wellness sales declined 14.8% to $1,157.0 million, despite approximately $35.5 million of Curlsmith sales.
- Organic sales: Consolidated organic sales declined 14.5%, reflecting weaker consumer demand, retailer inventory reductions and shifts in spending patterns. Acquisitions contributed $188.3 million of reported sales, while foreign currency reduced sales by approximately $17.0 million.
- Leadership Brands: Sales declined 3.1% to $1,753.7 million. Leadership Brands represented approximately 85% of consolidated sales.
- Interest and taxes: Interest expense increased to $40.8 million from $12.8 million because of higher debt and interest rates. The effective tax rate increased to 16.4% from 13.9%.
- Balance sheet: Cash and cash equivalents were $29.1 million. Inventory declined to $455.5 million from $558.0 million, while receivables declined to $377.6 million from $457.6 million.
- Capital spending: Capital and intangible asset expenditures were $174.9 million, including $147.0 million for construction of a new two-million-square-foot distribution facility.
Debt, Liquidity and Capital Allocation
- Credit Agreement borrowings totaled $936.9 million at February 28, 2023, consisting of $690.0 million of revolving loans and $246.9 million of term loans.
- The weighted-average interest rate on Credit Agreement borrowings was 6.6%. The Company hedged interest rates on $425 million of revolving debt through interest-rate swaps.
- Revolving availability was $541.8 million after considering $18.2 million of outstanding letters of credit.
- Total long-term debt maturities were $936.9 million, including $924.4 million due in fiscal 2026. The Credit Agreement matures March 13, 2025.
- The Company reported compliance with its debt covenants. The minimum interest coverage ratio was 3.00 to 1.00, and the maximum leverage ratio was 4.00 to 1.00 at February 28, 2023, stepping down thereafter.
- Fiscal 2024 expected cash requirements include approximately $57.9 million of interest, $31.0 million of Project Pegasus restructuring payments, $45 million to $50 million of capital expenditures, and $6.3 million of current debt maturities.
- The Board’s $500 million repurchase authorization had approximately $403.6 million remaining at February 28, 2023. Fiscal 2023 repurchases consisted of 90,462 shares acquired in connection with equity compensation; no open-market repurchases were reported.
- Management believes operating cash flow and available financing will be sufficient for foreseeable liquidity needs, although the filing identifies substantial debt refinancing requirements in fiscal 2025 and 2026.
Material Changes Versus the Prior Comparable Period
- Revenue declined because of lower consumer demand, retailer inventory rebalancing, lower online-channel sales and the completed Personal Care divestitures. Customer price increases and acquisitions partially offset the decline.
- Beauty & Wellness operating income declined to $77.7 million from $137.6 million, and operating margin fell to 6.7% from 10.1%. Home & Outdoor operating income was broadly flat at $134.1 million, but margin declined to 14.6% from 15.6%.
- Adjusted operating margin contracted despite a higher reported gross margin, primarily because of unfavorable operating leverage, distribution costs, salary and wage inflation, marketing expense and product mix.
- Operating cash flow improved because less cash was invested in inventory and receivables, partially offset by lower earnings and higher interest, restructuring and tax payments.
- Debt increased materially following the Curlsmith acquisition, distribution-facility construction and higher working-capital financing needs. Interest expense rose substantially as benchmark rates increased.
- Fiscal 2023 included a full year of Osprey results and approximately 45 weeks of Curlsmith results, limiting direct year-over-year comparability.
Guidance, Outlook, Commentary and Unusual Items
- Project Pegasus: Management targets annualized pre-tax operating profit improvements of approximately $75 million to $85 million, substantially beginning in fiscal 2024 and substantially achieved by fiscal 2026. Savings are expected to be recognized approximately 25% in fiscal 2024, 50% in fiscal 2025 and 25% in fiscal 2026.
- Expected Project Pegasus benefits are approximately 60% from lower cost of goods sold and 40% from lower SG&A. Total one-time restructuring charges are estimated at approximately $85 million to $95 million, substantially completed by the end of fiscal 2024.
- The restructuring is expected to reduce the global workforce by approximately 10%. Fiscal 2023 restructuring charges were $27.4 million, with $6.6 million accrued at year-end.
- EPA matter: Packaging compliance actions affected filtration and humidifier products. Repackaging and relabeling were completed during fiscal 2023. EPA compliance costs were $23.6 million in fiscal 2023 versus $32.4 million in fiscal 2022. The Company reported no known fines or penalties but stated that future penalties cannot be ruled out.
- Weather-related inventory loss: A March 2022 weather incident damaged inventory. The Company recorded a $34.4 million inventory write-off, fully offset by probable insurance recoveries, received $46.0 million of insurance proceeds, and recorded a net $9.7 million gain after disposal costs.
- Patent litigation: Brita’s PUR water-filtration patent action received an unfavorable Initial Determination from the ITC on February 28, 2023. The matter was subject to review, with a final ITC decision expected by June 28, 2023. The Company prepared an alternative replacement filter but could not estimate the potential loss or operational impact.
- Management expects continued uncertainty from inflation, higher interest rates, consumer spending changes, retailer inventory levels, supply-chain conditions, geopolitical events and foreign exchange movements.
Principal Risks
- High customer concentration: Amazon, Target and Walmart each represented approximately 10% or more of fiscal 2023 sales; the top five customers represented approximately 43%.
- Manufacturing concentration: approximately 87% of finished goods purchased in fiscal 2023 were manufactured in Asia, exposing the Company to tariffs, trade restrictions, geopolitical events, freight disruption and supplier risks.
- Approximately 74% of fiscal 2023 sales were from U.S. shipments, and approximately 56% of consolidated gross sales volume shipped from distribution facilities in northern Mississippi, creating geographic concentration risk.
- Variable-rate debt, significant fiscal 2026 maturities and higher SOFR create refinancing and interest-rate exposure. A hypothetical 1% increase in interest rates would increase annual interest expense by approximately $5.1 million after swaps, based on the filing’s analysis.
- Potential adverse outcomes from the Brita patent litigation or additional EPA regulatory actions could materially affect sales, costs and profitability.
- Additional risks include goodwill and intangible-asset impairment, cybersecurity incidents, product liability and recalls, licensed-trademark dependence, foreign currency volatility, ESG compliance and execution risk under Project Pegasus.
Investor Verification Items
- Verify the fiscal 2024 and fiscal 2026 debt-refinancing plan, including compliance with the step-down leverage covenant and availability under the Credit Agreement.
- Track whether Project Pegasus delivers the targeted $75 million to $85 million of annualized savings and whether restructuring costs remain within the $85 million to $95 million estimate.
- Assess whether Beauty & Wellness sales and margins stabilize after the consumer-demand decline, EPA remediation and retailer inventory reductions.
- Confirm the final outcome and economic impact of the Brita ITC and related patent litigation.
- Monitor the effect of higher interest rates, freight and product costs, tariffs, foreign exchange and continued retailer concentration on margins and cash flow.
- Reconcile reported and adjusted results, noting that management’s non-GAAP measures exclude restructuring, EPA compliance, acquisition-related costs, insurance gains, amortization and share-based compensation.